Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Maxim Group Reiterates Buy, $6 PT on IntelliPharmaCeutics (IPCI) as FDA Greenlights Generic Seroquel XR
-
Streetinsider.com's Hot Lunchtime Reads 12/31: (EGY) (SWHC) (AAPL) (VRX)
-
IntelliPharmaCeutics (IPCI) PT Lowered to $6 at Maxim Group
-
Unusual 11 Mid-Day Movers 9/8: (RADA) (MGAM) (BKYF) Higher; (VII) (ESYS) (DGLY) Lower
-
Unusual 11 Mid-Day Movers 9/5: (IVAN) (ANAD) (PRAN) Higher; (REPH) (ZQK) (AUMN) Lower
-
Notable Analyst Rating Changes 9/5: (IPCI) (CIEN) (BP) Upgraded; (TTWO) (PCLN) (MS) Downgraded
-
Pre-Open Stock Movers 9/5: (BLOX) (HURC) (AMBA) (LOCO) Higher; (REPH) (ZQK) (GPS) Lower (more...)
-
Maxim Group Upgrades IntelliPharmaCeutics International (IPCI) to Buy
-
Unusual 11 Mid-Day Movers 07/09: (SCOK) (NEON) (AVAV) Higher; (GIMO) (IPCI) (MCP) Lower
-
Maxim Group Downgrades IntelliPharmaCeutics International (IPCI) to Hold
-
IntelliPharmaCeutics (IPCI) Target Raised to $9 at Maxim Group
-
Streetinsider.com Pre-Open Movers 07/26: (ATVI) (SBUX) (GILD) Higher; (EXPE) (SWI) (ZNGA) Lower (more...)
-
Intellipharmaceutics (IPCI) Sink on Stock Offering
-
Intellipharmaceutics (IPCI) Commences $.1M Capital Raise Via Direct Offering
-
Maxim Group Starts IntelliPharmaCeutics International (IPCI) at Buy

